BRPI0519855A2 - derivados de hidroxifenol, processos para preparação dos mesmos, composições farmacêuticas compreendendo os mesmos e usos terapêuticos dos mesmos - Google Patents
derivados de hidroxifenol, processos para preparação dos mesmos, composições farmacêuticas compreendendo os mesmos e usos terapêuticos dos mesmosInfo
- Publication number
- BRPI0519855A2 BRPI0519855A2 BRPI0519855-0A BRPI0519855A BRPI0519855A2 BR PI0519855 A2 BRPI0519855 A2 BR PI0519855A2 BR PI0519855 A BRPI0519855 A BR PI0519855A BR PI0519855 A2 BRPI0519855 A2 BR PI0519855A2
- Authority
- BR
- Brazil
- Prior art keywords
- processes
- preparing
- pharmaceutical compositions
- therapeutic uses
- hydroxyphenol derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
- C07C323/62—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/20—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
- C07D295/205—Radicals derived from carbonic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/22—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and doubly-bound oxygen atoms bound to the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/76—Unsaturated compounds containing keto groups
- C07C59/90—Unsaturated compounds containing keto groups containing singly bound oxygen-containing groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D263/32—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
- C07D265/34—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
- C07D265/36—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings condensed with one six-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane
Abstract
DERIVADOS DE HIDROXIFENOL, PROCESSOS PARA PREPARAçãO DOS MESMOS, COMPOSIçõES FARMACêUTICAS COMPREENDENDO OS MESMOS E USOS TERAPEUTICOS DOS MESMOS. Compostos da fórmula (I): em que A, R¹, R², X, Y e Z são definidos na descrição, os processos para preparação desses compostos, usos dos mesmos para o tratamento de dislipidemia, aterosclerose e diabetes, e as composições farmacêuticas que compreendem os mesmos.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0500420A FR2880887B1 (fr) | 2005-01-14 | 2005-01-14 | Derives d'hydroxyphenols, procedes pour leur preparation, compositions pharmaceutiques les contenant et applications en therapeutique |
PCT/EP2005/013858 WO2006074798A1 (en) | 2005-01-14 | 2005-12-22 | Hydroxyphenol derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic uses thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0519855A2 true BRPI0519855A2 (pt) | 2009-03-24 |
Family
ID=35033619
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0519855-0A BRPI0519855A2 (pt) | 2005-01-14 | 2005-12-22 | derivados de hidroxifenol, processos para preparação dos mesmos, composições farmacêuticas compreendendo os mesmos e usos terapêuticos dos mesmos |
Country Status (16)
Country | Link |
---|---|
US (1) | US8653134B2 (pt) |
EP (1) | EP1836150B1 (pt) |
JP (1) | JP2008526904A (pt) |
KR (1) | KR20070092278A (pt) |
CN (1) | CN101098846A (pt) |
AR (1) | AR053115A1 (pt) |
AT (1) | ATE481377T1 (pt) |
AU (1) | AU2005324904B2 (pt) |
BR (1) | BRPI0519855A2 (pt) |
CA (1) | CA2594707C (pt) |
DE (1) | DE602005023659D1 (pt) |
ES (1) | ES2353149T3 (pt) |
FR (1) | FR2880887B1 (pt) |
MX (1) | MX2007008351A (pt) |
WO (1) | WO2006074798A1 (pt) |
ZA (1) | ZA200706706B (pt) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100877200B1 (ko) | 2007-09-11 | 2009-01-07 | 주식회사 동희산업 | 가속페달 장치의 킥 다운 스위치 |
JP5960839B2 (ja) * | 2012-11-15 | 2016-08-02 | 帝人株式会社 | 6,6’−(エチレンジオキシ)ジ−2−ナフトエ酸ジエステルの製造方法 |
EP3943771B1 (en) | 2020-07-21 | 2023-11-15 | Siemens Aktiengesellschaft | Method and apparatus of assembling one or more bearings |
Family Cites Families (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB860303A (en) * | 1958-06-20 | 1961-02-01 | Ici Ltd | Pharmaceutical compositions comprising ª‡-aryloxy-aliphatic carboxylic acids and/or ª |
BE654557A (pt) * | 1963-07-13 | |||
US3378582A (en) * | 1964-03-20 | 1968-04-16 | Merck & Co Inc | (alpha-phenoxy)-and (alpha-phenylthio)-omegaphenyl-alkanoic acids |
FR1498459A (pt) * | 1965-07-30 | 1968-01-08 | ||
BE759013R (fr) * | 1969-11-17 | 1971-05-17 | Ici Ltd | Derives de la |
DE2208893A1 (de) * | 1972-02-25 | 1973-08-30 | Boehringer Mannheim Gmbh | Tricyclische alpha-oxy-carbonsaeurederivate und verfahren zur herstellung derselben |
JPS518228A (ja) * | 1974-07-10 | 1976-01-23 | Takeda Chemical Industries Ltd | Chikanfuenokishikarubonsanruino seizoho |
JPS527426A (en) * | 1975-07-08 | 1977-01-20 | Ube Ind Ltd | Plant growth regulator |
GB1559977A (en) * | 1975-11-25 | 1980-01-30 | Ici Ltd | Amines |
JPS5732288A (en) * | 1980-07-14 | 1982-02-20 | Clin Midy | Tarampicillin 2-methoxyphenoxyacetate and manufacture |
US4983592A (en) * | 1988-12-19 | 1991-01-08 | American Cyanamid Co. | Bis-arylphosphate ester antagonists of platelet activating factor |
EP0525888A1 (en) * | 1991-07-29 | 1993-02-03 | Merck & Co. Inc. | New catechol type non-steroidal drugs as 5-alpha reductase inhibitors |
DE4142514A1 (de) * | 1991-12-21 | 1993-06-24 | Basf Ag | Verfahren zur bekaempfung von pilzen |
JPH07173143A (ja) * | 1993-12-17 | 1995-07-11 | Wakamoto Pharmaceut Co Ltd | 新規2−チオキソ−4−チアゾリジノン誘導体及び医薬 |
WO1995022323A1 (en) * | 1994-02-16 | 1995-08-24 | Idun Pharmaceuticals | Methods for controlling free radical generation by inflammatory cells |
WO1998013347A1 (en) * | 1996-09-26 | 1998-04-02 | Novartis Ag | Aryl-substituted acrylamides with leukotriene b4 (ltb-4) receptor antagonist activity |
AU8750298A (en) * | 1997-08-28 | 1999-03-22 | Ono Pharmaceutical Co. Ltd. | Peroxisome proliferator-activated receptor controllers |
ATE427925T1 (de) * | 1999-11-05 | 2009-04-15 | Emisphere Tech Inc | Phenoxycarbonsaureverbindungen und zusammensetzungen zur verabreichung aktiver wirkstoffe |
KR20020081424A (ko) * | 2000-03-09 | 2002-10-26 | 아벤티스 파마 도이칠란트 게엠베하 | Ppar 매개인자의 치료학적 용도 |
ATE362468T1 (de) * | 2000-07-25 | 2007-06-15 | Merck & Co Inc | N-substituierte indole mit anwendung in der behandlung von diabetes |
MXPA04001253A (es) * | 2001-08-09 | 2004-06-03 | Ono Pharmaceutical Co | Derivados de acidos carboxilicos y agente farmaceutico que comprende los mismos como ingrediente activo. |
DE10142665B4 (de) * | 2001-08-31 | 2004-05-06 | Aventis Pharma Deutschland Gmbh | C2-Disubstituierte Indan-1-one und ihre Derivate |
EP1615698B1 (en) * | 2003-04-11 | 2010-09-29 | High Point Pharmaceuticals, LLC | New amide derivatives and pharmaceutical use thereof |
WO2004089416A2 (en) * | 2003-04-11 | 2004-10-21 | Novo Nordisk A/S | Combination of an 11beta-hydroxysteroid dehydrogenase type 1 inhibitor and an antihypertensive agent |
JPWO2005012221A1 (ja) * | 2003-08-04 | 2006-09-14 | 小野薬品工業株式会社 | ジフェニルエーテル化合物、その製造方法および用途 |
KR20060037442A (ko) * | 2003-08-14 | 2006-05-03 | 화이자 인코포레이티드 | Hiv 감염 치료용 피페라진 유도체 |
WO2005035495A2 (en) * | 2003-10-08 | 2005-04-21 | Nicholas Piramal India Limited | Fibrinogen receptor antagonists and their use |
CA2451175A1 (en) * | 2003-11-26 | 2005-05-26 | Torcan Chemical Ltd. | Process for the preparation of tamsulosin |
US7544803B2 (en) * | 2004-01-23 | 2009-06-09 | Amgen Inc. | Vanilloid receptor ligands and their use in treatments |
JP2005298437A (ja) * | 2004-04-15 | 2005-10-27 | Astellas Pharma Inc | 3−キノリン−2(1h)−イリデンインドリン−2−オン誘導体 |
FR2869611B1 (fr) * | 2004-05-03 | 2006-07-28 | Merck Sante Soc Par Actions Si | Derives de l'acide hexenoique, procedes pour leur preparation, compositions pharmaceutiques les contenant et applications en therapeutique |
CA2565188C (en) * | 2004-05-14 | 2014-03-04 | Emisphere Technologies, Inc. | Compounds and compositions for delivering active agents |
US20080255078A1 (en) * | 2005-11-22 | 2008-10-16 | Subba Reddy Katamreddy | Triphenylethylene Compounds Useful as Selective Estrogen Receptor Modulators |
EP1951217A4 (en) * | 2005-11-22 | 2009-08-12 | Smithkline Beecham Corp | CHEMICAL COMPOUNDS |
-
2005
- 2005-01-14 FR FR0500420A patent/FR2880887B1/fr not_active Expired - Fee Related
- 2005-12-22 JP JP2007550706A patent/JP2008526904A/ja active Pending
- 2005-12-22 AT AT05823908T patent/ATE481377T1/de not_active IP Right Cessation
- 2005-12-22 DE DE602005023659T patent/DE602005023659D1/de active Active
- 2005-12-22 US US11/813,933 patent/US8653134B2/en not_active Expired - Fee Related
- 2005-12-22 MX MX2007008351A patent/MX2007008351A/es not_active Application Discontinuation
- 2005-12-22 AU AU2005324904A patent/AU2005324904B2/en not_active Ceased
- 2005-12-22 CA CA2594707A patent/CA2594707C/en not_active Expired - Fee Related
- 2005-12-22 EP EP05823908A patent/EP1836150B1/en not_active Not-in-force
- 2005-12-22 BR BRPI0519855-0A patent/BRPI0519855A2/pt not_active Application Discontinuation
- 2005-12-22 ES ES05823908T patent/ES2353149T3/es active Active
- 2005-12-22 KR KR1020077016038A patent/KR20070092278A/ko not_active Application Discontinuation
- 2005-12-22 CN CNA2005800465455A patent/CN101098846A/zh active Pending
- 2005-12-22 WO PCT/EP2005/013858 patent/WO2006074798A1/en active Application Filing
-
2006
- 2006-01-13 AR ARP060100137A patent/AR053115A1/es unknown
-
2007
- 2007-08-13 ZA ZA200706706A patent/ZA200706706B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
FR2880887A1 (fr) | 2006-07-21 |
AU2005324904B2 (en) | 2011-10-13 |
CA2594707A1 (en) | 2006-07-20 |
AU2005324904A1 (en) | 2006-07-20 |
WO2006074798A1 (en) | 2006-07-20 |
AR053115A1 (es) | 2007-04-25 |
EP1836150A1 (en) | 2007-09-26 |
CA2594707C (en) | 2013-10-22 |
MX2007008351A (es) | 2007-07-25 |
KR20070092278A (ko) | 2007-09-12 |
CN101098846A (zh) | 2008-01-02 |
US8653134B2 (en) | 2014-02-18 |
EP1836150B1 (en) | 2010-09-15 |
ES2353149T3 (es) | 2011-02-25 |
ATE481377T1 (de) | 2010-10-15 |
FR2880887B1 (fr) | 2009-01-30 |
JP2008526904A (ja) | 2008-07-24 |
DE602005023659D1 (de) | 2010-10-28 |
US20080161308A1 (en) | 2008-07-03 |
ZA200706706B (en) | 2008-09-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UY30472A1 (es) | Nuevos derivados de pirimidina, procesos para su preparacion composiciones farmacéuticas conteniédolos, procesos para su preparacion y aplicaciones. | |
BR112012032234A2 (pt) | "derivados de heteroaril imidazolona como inibidores de jak". | |
BRPI0512974A (pt) | novos derivados de hidantoìna para o tratamento de doenças obstrutivas das vias aéreas | |
BR112012027034A2 (pt) | inibidores da arginase e suas aplicações terapêuticas | |
NO20090295L (no) | Substituerte heteroarylderivater | |
ECSP077271A (es) | Derivados de pirimidina | |
CL2008002076A1 (es) | Compuestos derivados de ariloxazoles sustituidos; procedimiento de preparacion de dichos compuestos; composicion farmaceutica que los comprende; y su uso para tratar diabetes, sindrome metabolico, dislipidemias, entre otras enfermedades. | |
DK2024352T3 (da) | Glucopyranosylsubstituerede benzoenitrilderivater, farmaceutiske sammensætninger indeholdende sådanne forbindelser, deres anvendelse og fremgangsmåde for deres fremstilling | |
BRPI0607583A2 (pt) | derivados de piridin-2-carboxamida como antagonistas mglur5, método para sua preparação, medicamento contendo os mesmos, bem como uso relacionado aos referidos compostos | |
UY30976A1 (es) | Nuevos derivados de quinolina, composiciones farmaccuticas que los contienen, procesos de preparacion y aplicaciones. | |
ECSP077259A (es) | Derivados de pirimidina | |
UY30559A1 (es) | Derivados de morfolino pirimidina, procesos de preparacion, composiciones conteniéndolos y aplicaciones | |
BR112014013974A2 (pt) | derivados de sulfonamida benzílicos como moduladores de rorc | |
UY29607A1 (es) | Compuestos quimicos | |
ECSP11011184A (es) | Compuestos orgánicos | |
CR20110309A (es) | Compuestos orgánicos | |
BRPI0613754B8 (pt) | compostos, éster de um composto, composições farmacêuticas que compreendem o composto, método para o tratamento terapêutico e/ou profilático de enfermidades que são moduladas por análogos de hormônio de tireóide e utilização dos compostos | |
UY30444A1 (es) | Derivados de pirimidina, procesos para su preparacinn, composiciones farmaccuticos y usos de los mismos. | |
UY30759A1 (es) | Compuestos quimicos | |
BRPI0712631A8 (pt) | compostos, processos para a preparação de um composto, composição farmacêutica, uso de um composto e combinações | |
UY29675A1 (es) | Nuevos derivados de 1,1-dióxido de 1,4-benzotiazepina con mejores propiedades, procedimiento para su preparacion, medicamentoss que comprenden este compuestoy su uso. | |
BRPI0507198A (pt) | derivados de bisariluréia | |
NO20084850L (no) | MGLUR5 modulatorer I | |
BR112012011793A2 (pt) | "acrilamidas heterocíclicas e seu uso como farmacêuticos" | |
UY29767A1 (es) | Derivados de benzotiazolonas, procesos para su preparación, composiciones farmacéuticas que los contienen y aplicaciones |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B11A | Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing | ||
B11Y | Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette] |